Teva CEO Kare Schultz On Drugmaker's Outlook, Coronavirus Response
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Sell Teva Pharmaceutical due to increasing generic drugs competition: Credit Suisse
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel
DA SPOT NYC - CNBC Interview on Phase 1 Reopening
We see a stable U.S. market place for our generics, says Teva Pharma CEO
Allergan to own 10% stake in Teva
Teva stock plummets 18% after rough quarter in US generic drug market
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz
The Exchange on Twitter: "Legendary investor Bill Miller told @KellyCNBC it's still a bull market...and that there's opportunity in #value names and #bitcoin too @B3_MillerValue @MillerValue @CNBCTheExchange @CNBC #Investing #BTC $BTC $TEVA
CNBC on Twitter: "BREAKING: Warren Buffett's Berkshire Hathaway takes stake in Teva Pharma.; stock jumps after-hours. https://t.co/YKho1O67Ek https://t.co/bn0ijczjFc" / Twitter
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Teva shares surge after announcing global opioid settlement
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Meg Tirrell on Twitter: "$TEVA up on new Berkshire Hathaway stake https://t.co/z6sWdVF1TT" / Twitter
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
Teva Pharma CEO: We see a stable U.S. market place for our generics - YouTube
Three-Stock Lunch: AMD, HAS & TEVA
You cannot critique us for trying to help,' says Teva CEO on sustainability-linked bond launch
Catherine Gulka - Associate Director Marketing Digital Solutions at Teva Pharmaceuticals - Teva Pharmaceuticals | LinkedIn
Teva to acquire Allergan for $40B
Watch CNBC's full interview with Teva Pharmaceuticals CEO Kare Schultz - YouTube
